Benign leiomyoma with endometriosis (controls excluding all cancers)

Endpoint Browser PheWeb

CD2_LEIOMYOMA_ENDOMETRIOSIS_EXALLC

No definition available.

Endpoint definition

↥

FinnGen phenotype data

individuals

Apply sex-specific rule

Sex only females

Check conditions

N14_ENDOMETRIOSIS

Check pre-conditions, main-only, mode, registry filters None

0 out of 7 registries used, show all original rules.

Check minimum number of events None

Include endpoints

CD2_BENIGN_LEIOMYOMA_UTERI

Remove individuals based on genotype QC

5199

CD2_LEIOMYOMA_ENDOMETRIOSIS_EXALLC

Control definitions

Control exclude C3_CANCER

Control conditions not N14_ENDOMETRIOSIS

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF10

NAME	CD2_LEIOMYOMA_ENDOMETRIOSIS_EXALLC
CONTROL_EXCLUDE	C3_CANCER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!N14_ENDOMETRIOSIS
SEX	2
INCLUDE	CD2_BENIGN_LEIOMYOMA_UTERI
PRE_CONDITIONS
CONDITIONS	N14_ENDOMETRIOSIS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

No upset plot: script not run.

No upset table: script not run.

Similar endpoints

↥

List of similar endpoints to Benign leiomyoma with endometriosis (controls excluding all cancers) based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Benign leiomyoma with endometriosis

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	5199	5199	-
Unadjusted prevalence (%)	1.26	2.26	-
Mean age at first event (years)	43.94	43.94	-

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.01	0.48 [0.35, 0.66]	4.1e-6	289
15 years	0.00	0.31 [0.22, 0.44]	2.6e-11	77
5 years	0.00	0.28 [0.16, 0.50]	1.6e-5	14
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_LEIOMYOMA_ENDOMETRIOSIS_EXALLC – Benign leiomyoma with endometriosis (controls excluding all cancers)
GWS hits: 14

Survival analyses between endpoints

↥

Plot

before Benign leiomyoma with endometriosis (controls excluding all cancers)
after Benign leiomyoma with endometriosis (controls excluding all cancers)

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Benign leiomyoma with endometriosis (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.

≡ Risteys

R10

R9

R8

R7

R6

R5

R4

R3